Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced its audited consolidated financial results for the year ending December 31, 2024. The results, prepared in accordance with China Accounting Standards for Business Enterprises, reflect the company’s ongoing commitment to transparency and adherence to regulatory standards, potentially impacting its market positioning and stakeholder confidence.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, operating within the pharmaceutical industry. The company is involved in the production and sale of pharmaceutical products and is listed on both the Hong Kong Stock Exchange and the Shenzhen Stock Exchange.
YTD Price Performance: -0.69%
Average Trading Volume: 3,436,257
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$9.16B
See more insights into 0719 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue